ArticleBMJ open2022

Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial.

Kara-Louise Royle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.